Question 31

Zaleplon is listed as a Schedule IV controlled substance.

Zaleplon is classified under Schedule IV according to federal law, which indicates that it has a lower potential for abuse compared to substances in higher schedules. This classification reflects its accepted medical use in the United States.

A) II

Schedule II substances have a high potential for abuse, leading to severe psychological or physical dependence. Zaleplon does not fit this category as it is recognized for its lower abuse potential and is thus not classified as a Schedule II drug.

B) III

Schedule III substances have a moderate to low potential for physical and psychological dependence. Although zaleplon is not classified as Schedule III, this schedule is still higher than Schedule IV, indicating more potential for abuse than what is applicable to zaleplon.

C) IV

Zaleplon is accurately classified as a Schedule IV controlled substance, which signifies that it has a lower potential for abuse relative to substances in Schedules I-III. This classification aligns with its medical use primarily as a short-term treatment for insomnia.

D) V

Schedule V substances are considered to have the lowest potential for abuse and typically consist of preparations containing limited quantities of certain narcotics. Zaleplon is not classified as Schedule V, as it is deemed to have a higher potential for abuse than substances in this schedule.

Conclusion

Zaleplon's classification as a Schedule IV controlled substance is definitive due to its recognized medical use and lower potential for abuse compared to higher schedules. Other options, such as Schedule II and III, reflect substances that are associated with greater risks of abuse and dependence, while Schedule V encompasses drugs with even lower potential. Hence, none of the other options accurately represent zaleplon's status under federal law.